Arcadia Biosciences Inc.

NASDAQ: RKDA · Real-Time Price · USD
4.41
-0.22 (-4.75%)
At close: Aug 14, 2025, 3:40 PM
4.35
-1.36%
Pre-market: Aug 15, 2025, 08:00 AM EDT

Arcadia Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-7.04M -13.99M -15.61M -16.13M
Depreciation & Amortization
113K 984K 479K 1.04M
Stock-Based Compensation
512K 717K 1.11M 1.54M
Other Working Capital
315K -3.61M 97K -125K
Other Non-Cash Items
-2.62M 499K -1M 492K
Deferred Income Tax
n/a n/a n/a -9.89M
Change in Working Capital
-596K -3.51M 1.05M -2.92M
Operating Cash Flow
-9.63M -15.29M -13.98M -25.87M
Capital Expenditures
-16K -5K -72K -1.01M
Cash Acquisitions
n/a 569K 569K -4.25M
Purchase of Investments
n/a -7.53M -569K 25.15M
Sales Maturities Of Investments
5.02M 2.5M 569K 21.85M
Other Investing Acitivies
2.33M 115K 920K -25.13M
Investing Cash Flow
7.34M -4.34M 1.42M 16.61M
Debt Repayment
n/a n/a n/a -2.15M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
9K -485K -481K -1.1M
Financial Cash Flow
9K 5.51M 4.52M 21.9M
Net Cash Flow
-2.28M -14.13M -8.04M 12.64M
Free Cash Flow
-9.64M -15.3M -14.05M -26.88M